Saliva key to AI-assisted, non-invasive home monitoring method to improve epilepsy care
CORVALLIS, Ore. – Researchers at Oregon State University are poised to use saliva to make a personalized-medicine breakthrough for people with epilepsy thanks to a four-year, $1.2 million grant from the National Institutes of Health.
The OSU team had already demonstrated a sensor system, based on microfluidics, for quickly analyzing the level of anti-seizure medicine in saliva and now will extend its work to create a device, powered by artificial intelligence, that’s designed to optimize dosing.